Aesthetic practitioner and medical director of the Laser and Light Cosmetic Medical Skin Clinic, Dr Tahera Bhojani-Lynch has won the award for best European paper award in Plastic and Reconstructive Surgery – Global Open for 2017.
Spanish pharmaceutical company Almirall has entered into an agreement to acquire Allergan’s US medical dermatology unit portfolio, consisting of five brands for acne and dermatoses treatment.
Dermatological company SkinMed has announced the launch of its new acne treatment system, Acne TripleLock.
Product distributor, SkinMed has launched two new products designed for treating oily and problematic skin.
A study released at the British Association of Dermatologists annual meeting suggests that patients are exceeding the recommended time of antibiotic use for acne before being referred to a dermatologist.
Dermatological distribution company SkinMed has introduced the new OSK Chest and Back to its Tebiskin range. The Tebiskin range aims to combat resistant acne on the face and neck. The new addition to the range is a spray that aims to treat chest and back acne and reduce inflammation. SkinMed claims the spray is easy to apply and absorbs without rubbing in, making it easy for the patient to use at home. The company claims the key ingredients act to kill acne bacteria faster than prescription combinations and helps to restore the skin’s lipid balance. The Tebiskin OSK Chest and Back does not contain any antibiotics, benzoyl peroxide or retinoids and can also be used in combination with EnerPeel 30% Salicylic acid Chest and Back.
A recent study on patients with minocycline-induced pigmentation (MIP) indicated ‘superior clearance’ of the reaction when treated with a picosecond alexandrite laser.